Spikevax, also known as the Moderna COVID-19 vaccine, uses mRNA technology to create a protein that triggers the immune system to fight off COVID-19. It is highly effective at preventing the virus and has been authorized for use in several countries for people aged 18 and over, and in some countries for those aged 12 and over. Vaccination with Spikevax is crucial for protection against the virus.